KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News
March 6, 2025
KHA will visit Washington, DC, May 5-7, and invites members to accompany the advocacy team to meet in person with Kentucky’s congressional delegation.
News Podcast
March 5, 2025
KHA Vice President of Clinical Strategy and Transformation Deb Campbell discusses sexual assault nurse examiners (SANEs), SANE-Ready Hospitals, and how KHA is working to help survivors.